Treatment

SAN FRANCISCO, Dec. 6, 2022 /PRNewswire/ -- The diaTribe Foundation, Advanced Technologies & Treatments for Diabetes (ATTD), and the Time in Range Coalition announced today a new international consensus regarding continuous glucose…

BOSTON, Mass. and NOIDA, India, Dec. 6, 2022 /PRNewswire/ -- Curadev Pharma, a small molecule drug discovery and development company focused on the generation of novel therapeutics for the treatment of intractable diseases such as cancer…

TAMPA, Fla., Dec. 2, 2022 /PRNewswire/ -- VEITH 2022 witnessed a surge of supporting clinical data for Sirolimus Coated Balloon in the treatment of Below-the-Knee (BTK) disease. Concept Medical Inc. hosted a lunch symposium titled…

TOKYO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The Global Water and Wastewater Treatment Equipment Market Size accounted for USD 32.7 Billion in 2021 and is projected to occupy a market size of USD 52.2 Billion by 2030 growing at a CAGR of…

China has the world’s largest iron deficiency anemia population with estimated prevalence of 15%1 Approval may also benefit the Chinese healthcare system, among others through implementation of a more effective patient blood management…

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that HIBRUKA (orelabrutinib) has been approved by the Health Sciences…

OMAHA, Neb.--(BUSINESS WIRE)--Amber Specialty Pharmacy announces that it will begin dispensing TZIELD™ (teplizumab), an anti-CD3 monoclonal antibody, to delay Stage 3 Type 1 Diabetes (T1D) in patients ages 8 years and older with Stage 2…

Phase 2 clinical trial investigating KP1077 in patients with IH expected to initiate prior to year-end 2022

BEIJING & BURLINGTON, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals, Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development and commercialization of transformative…

Dupixent® (dupilumab) recommended for EU approval by the CHMP for the treatment of prurigo nodularis